Insights

  • Date

  • Content Type

  • Reset

Article

Managing the Complex Regulatory Pathways for Bioprinting Breakthroughs

20.12.22

By Elena Meurer and Mariya Gromova

Bioprinted products are already starting to demonstrate life-changing potential, but the path to commercialisation is
Read More

Article

Reimbursement of ATMPs in Germany: Challenges, opportunities and key initiatives

15.11.22

By Liron Sarid-Krebs ,Carolin Denzinger , Zaklina Buljovcic

Liron Sarid-Krebs Associate Principal Consultant and Team Lead at Biopharma Excellence. Carolin Denzinger  Director, Head
Read More

Article

Vaccine Equity for Africa: A moment of pride for the Biopharma Excellence team

8.11.22
by Michael Pfleiderer, Ph.D., principal consultant and senior director When our team from Biopharma Excellence
Read More

Article

Why Regulatory Convergence is Key to Global Development of Cell and Gene Therapies

17.10.22

By Francesco Lanucara

There is growing excitement about the potential shown by cell and gene therapies, particularly in | Read Time 5min
Read More

Article

Challenge accepted: Teams seeking a quantum shift for new antiviral agents through Germany’s federal agency SPRIN-D

20.09.22

By Dr. Maximilian Strunz

In 2021, the German Federal Agency for Disruptive Innovation, SPRIN-D, announced an antiviral challenge to
Read More

Article

SCIENTIFIC DUE DILIGENCE BUILDS BETTER BUSINESS RELATIONSHIPS

13.09.22

By Dr. Diane Seimetz & Jörg Schneider

The biopharma sector is seeing a proliferation of mergers, partnerships and acquisitions, but deals can
Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more